Literature DB >> 11722428

High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene.

P W Kamphuisen1, J C Eikenboom, F R Rosendaal, T Koster, A D Blann, H L Vos, R M Bertina.   

Abstract

High factor VIII levels increase the risk of venous thromboembolism, but the mechanisms that cause high factor VIII levels are unclear. In 301 thrombosis patients and 301 matched healthy controls, factor VIII antigen (VIII:Ag) levels > or = 150 IU/dl increased the thrombosis risk more than fivefold. We investigated whether high factor VIII:Ag levels result from a genetic variation in the factor VIII or von Willebrand factor (VWF) genes. Six polymorphisms in the VWF gene and two CA-repeats in the factor VIII gene were not associated with plasma VWF levels, factor VIII:Ag levels, or thrombosis risk. Our data do not support the hypothesis that a single functional sequence variation in the factor VIII or VWF gene explains the majority of high factor VIII levels and thrombotic risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722428     DOI: 10.1046/j.1365-2141.2001.03089.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

2.  Coagulation factor VIII levels are associated with long-term survival - interactions with gender in a large hospital-based cohort.

Authors:  Florian M Kovar; Claudia L Marsik; Christian Joukhadar; Thomas Perkmann; Helmuth Haslacher; Thomas Schickbauer; Paul A Kyrle; Oswald F Wagner; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2010-06-25       Impact factor: 1.704

Review 3.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

4.  Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.

Authors:  J A Heit; J M Cunningham; T M Petterson; S M Armasu; D N Rider; M DE Andrade
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

5.  A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

Authors:  J A Heit; S M Armasu; Y W Asmann; J M Cunningham; M E Matsumoto; T M Petterson; M De Andrade
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

6.  ABO blood group influences transfusion and survival after cardiac surgery.

Authors:  Ian J Welsby; Barbara Phillips-Bute; Joseph P Mathew; Mark F Newman; Richard Becker; Sunil Rao; Carmelo A Milano; Mark Stafford-Smith
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

7.  High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.

Authors:  Martin Mohren; Kathleen Jentsch-Ullrich; Michael Koenigsmann; Siegfried Kropf; Enrico Schalk; Gerd Lutze
Journal:  Int J Hematol       Date:  2015-11-26       Impact factor: 2.490

Review 8.  Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.

Authors:  Herbert H Watzke
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

9.  Elevated Von Willebrand Factor Antigen Levels are an Independent Risk Factor for Venous Thromboembolism: First Report from North India.

Authors:  Sweta Rajpal; Jasmina Ahluwalia; Narender Kumar; Pankaj Malhotra; Varun Uppal
Journal:  Indian J Hematol Blood Transfus       Date:  2019-02-15       Impact factor: 0.900

10.  Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism.

Authors:  Luis F Bittar; Lucia H Siqueira; Fernanda A Orsi; Erich V De Paula; Joyce M Annichino-Bizzacchi
Journal:  Sci Rep       Date:  2015-03-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.